NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 30 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2023. The put-call ratio across all filers is 8.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31 | -3.1% | 350 | 0.0% | 0.00% | – |
| Q2 2023 | $32 | -64.8% | 350 | 0.0% | 0.00% | – |
| Q1 2023 | $91 | +23.0% | 350 | 0.0% | 0.00% | – |
| Q4 2022 | $74 | – | 350 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 350 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 350 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 350 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 350 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 350 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 36,838 | $26,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 102,440 | $74,000 | 0.00% |
| PDS Planning, Inc | 10,565 | $8,000 | 0.00% |
| UBS Group AG | 105 | $0 | 0.00% |
| Parallel Advisors, LLC | 350 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,722 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,954 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 39,414 | $28,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 227,452 | $164,000 | 0.00% |